EZRA FRIEDBERG

Profile

First Name

: EZRA

Middle Name

:

Last Name

: FRIEDBERG

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
MULTIPLIER CAPITAL, LP
RAY BOONE, EZRA FREIDBERG, * MULTIPLIER CAPITAL GP, LLC, N/A MULTIPLIER CAPITAL GP, LLC, N/A N/A MULTIPLIER CAPITAL GP, LLC, HENRY O-CONNOR, KEVIN SHEEHAN, KEVIN P. SHEEHAN
EXECUTIVE OFFICER
MULTIPLIER GROWTH PARTNERS SPV I, LP
RAY BOONE, NOT APPLICABLE MULTIPLIER CAPITAL, LLC, HENRY O-CONNOR, KEVIN P. SHEEHAN
DIRECTOR
KALOBIOS PHARMACEUTICALS INC
RONALD BARLIANT, RAINER BOEHM, DALE CHAPPELL, CAMERON DURRANT, DENISE GILBERT, MICHAEL HARRISON, JAMES HEALY, DENNIS HENNER, GREG JESTER, JEANNE JEW, MORGAN LAM, TED LOVE, GARY LYONS, DAVID MORADI, TIMOTHY MORRIS, DAVID PRITCHARD, ROBERT SAVAGE, BRIGITTE SMITH, RAY WITHY, DEAN WITTER III
EXECUTIVE OFFICER
MULTIPLIER CAPITAL II, LP
RAY BOONE, GENERAL PARTNER MULTIPLIER CAPITAL II GP, LLC, N/A MULTIPLIER CAPITAL II GP, LLC, HENRY OCONNOR, KEVIN P. SHEEHAN
DIRECTOR
HUMANIGEN, INC
RONALD BARLIANT, RAINER BOEHM, DALE CHAPPELL, CAMERON DURRANT, DENISE GILBERT, MICHAEL HARRISON, JAMES HEALY, DENNIS HENNER, GREG JESTER, JEANNE JEW, MORGAN LAM, TED LOVE, GARY LYONS, DAVID MORADI, TIMOTHY MORRIS, DAVID PRITCHARD, ROBERT SAVAGE, BRIGITTE SMITH, RAY WITHY, DEAN WITTER III
EXECUTIVE OFFICER
MULTIPLIER CAPITAL III, LP
RAY BOONE, CHARLES WILSON KING, N/A MULTIPLIER CAPITAL III GP, LLC, HENRY O-CONNOR, KEVIN SHEEHAN
DIRECTOR
CHROMOCELL THERAPEUTICS CORP
RICHARD BAXTER, TODD DAVIS, PETER GREENLEAF, FRANCIS KNUETTEL, FRANCIS KNUETTEL II, ERIC LANG, RICHARD MALAMUT, MATTHEW PAULS, SCOTT PLESHA, SAI RANGARAO, CHIA-LIN SIMMONS
DIRECTOR
PELTHOS THERAPEUTICS INC.
RICHARD BAXTER, TODD DAVIS, PETER GREENLEAF, FRANCIS KNUETTEL, FRANCIS KNUETTEL II, ERIC LANG, RICHARD MALAMUT, MATTHEW PAULS, SCOTT PLESHA, SAI RANGARAO, CHIA-LIN SIMMONS
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-11-19
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2025-11-06 
2025-07-10
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2025-07-01 
2024-08-06
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Debt 
2024-07-24 
2023-01-05
D/A
Link
OTHER INVESTMENT FUND 
 
 
Equity 
2021-12-20 
2022-10-18
D/A
Link
OTHER INVESTMENT FUND 
 
 
Equity 
2021-12-20 
2022-01-03
D
Link
OTHER INVESTMENT FUND 
 
 
Equity 
2021-12-20 
2017-10-13
D/A
Link
PRIVATE EQUITY FUND 
 
OVER $100,000,000 
Equity 
2016-07-20 
2017-09-05
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-08-23 
2016-08-02
D
Link
PRIVATE EQUITY FUND 
 
$25,000,001 - $100,000,000 
Equity 
2016-07-20 
2016-07-15
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-06-30 
2015-07-24
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-16 
2013-06-20
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2012-04-20 
2012-11-21
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2012-04-20 
2012-05-03
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
Equity 
2012-04-20